Zobrazeno 61 - 70
of 88
pro vyhledávání: '"35"'
Autor:
Hans Edmund Eckel
Publikováno v:
Annals of Otology, Rhinology & Laryngology. 110:7-15
Although transoral laser surgery (TLS) for the treatment of early stage glottic carcinoma is now widely used, the patterns of local recurrences, related re-treatment methods, and results have not been documented comprehensively. Two hundred fifty-two
Autor:
John L. Dornhoffer
Publikováno v:
Annals of Otology, Rhinology & Laryngology. 109:1033-1039
The goal of this retrospective study was to report the preliminary results of the retrograde mastoidectomy technique with canal wall reconstruction used as a primary treatment method for cholesteatoma. This synthesis of canal wall up (CWU) and canal
Publikováno v:
The International Journal of Biological Markers. 15:147-152
This retrospective study was undertaken in order to assess the prognostic value of prechemotherapy serum CA125 level, CA125 kinetics, and CA125 half-life compared to the ten common clinicopathological variables in patients with advanced ovarian cance
Publikováno v:
Annals of Otology, Rhinology & Laryngology. 108:677-682
Leiomyosarcoma of the larynx is an extremely rare malignancy. Until now, only 35 cases have been reported, and only 19 were reported in English. We present 2 new cases observed in the last 3 years at our department. Correct histologic diagnosis can o
Publikováno v:
The International Journal of Biological Markers. 14:55-59
Humanized anti-c-erbB-2 antibodies (Herceptin®) in a weekly schedule are a new therapeutic option for the treatment of c-erbB-2-positive, advanced breast cancer (ABC). Addition of Herceptin® to first-line chemotherapy for c-erbB-2 overexpressing AB
Autor:
Nadia Cardarelli, Stefano Cascinu, Ettore Tito Menichetti, Giuseppina Catalano, Massimo Marcellini, Francesco Graziano
Publikováno v:
Scopus-Elsevier
Aims and background The study was performed to assess the feasibility and activity of an intensive chemotherapeutic regimen as adjuvant treatment for patients with resected gastric cancer at high risk of recurrence (PT2N1-2; pT3-4Nany M0). Patients a
Publikováno v:
Ear, Nose & Throat Journal. 76:528-536
Allergic rhinitis has been conservatively estimated to affect 35 million Americans, with an annual US expenditure of more than $2 billion for treatment. Immunotherapy is generally administered to patients with allergic rhinitis when avoidance is impo
Publikováno v:
Annals of Otology, Rhinology & Laryngology. 106:633-639
In a rat model, we investigated the role of tumor necrosis factor (TNF) and interleukin-1 (IL-1) in endotoxin-induced middle ear effusions (MEEs). After the eustachian tube was obstructed, the middle ear was transtympanically injected with 35 microL
Autor:
Jane P Matthews, Karen M Howitt
Publikováno v:
Journal of Oncology Pharmacy Practice. 3:68-75
Objective. To identify if prophylactic granulocyte colony-stimulating factor (G-CSF) delivers the same clinical outcome and level of cost-effectiveness in general clinical use as it has under controlled clinical trial conditions in patients with non-
Publikováno v:
Annals of Otology, Rhinology & Laryngology. 105:1-5
Despite the risk of airway obstruction, tracheotomy has been viewed with trepidation in the management of recurrent respiratory papillomatosis (RRP). The literature suggests that the injury associated with the tracheotomy site may initiate the progre